Spero Therapeutics, Inc. (SPRO)
2.30
-0.02
(-0.86%)
USD |
NASDAQ |
Dec 29, 16:00
2.29
-0.01
(-0.43%)
After-Hours: 20:00
Spero Therapeutics Shareholders Equity (Quarterly): 26.49M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | 6.057B |
| Amicus Therapeutics, Inc. | 230.42M |
| Cassava Sciences, Inc. | 81.57M |
| Omeros Corp. | -220.48M |
| GeoVax Labs, Inc. | 4.907M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 54.17M |
| Total Liabilities (Quarterly) | 27.68M |
| Debt to Equity Ratio | 0.1265 |
| Current Ratio | 3.834 |
| Net Debt Paydown Yield | 0.30% |